437 related articles for article (PubMed ID: 24726726)
1. Molecular insights into NF2/Merlin tumor suppressor function.
Cooper J; Giancotti FG
FEBS Lett; 2014 Aug; 588(16):2743-52. PubMed ID: 24726726
[TBL] [Abstract][Full Text] [Related]
2. Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus.
Li W; You L; Cooper J; Schiavon G; Pepe-Caprio A; Zhou L; Ishii R; Giovannini M; Hanemann CO; Long SB; Erdjument-Bromage H; Zhou P; Tempst P; Giancotti FG
Cell; 2010 Feb; 140(4):477-90. PubMed ID: 20178741
[TBL] [Abstract][Full Text] [Related]
3. Merlin/NF2 functions upstream of the nuclear E3 ubiquitin ligase CRL4DCAF1 to suppress oncogenic gene expression.
Cooper J; Li W; You L; Schiavon G; Pepe-Caprio A; Zhou L; Ishii R; Giovannini M; Hanemann CO; Long SB; Erdjument-Bromage H; Zhou P; Tempst P; Giancotti FG
Sci Signal; 2011 Aug; 4(188):pt6. PubMed ID: 21878678
[TBL] [Abstract][Full Text] [Related]
4. Merlin's tumor suppression linked to inhibition of the E3 ubiquitin ligase CRL4 (DCAF1).
Li W; Giancotti FG
Cell Cycle; 2010 Nov; 9(22):4433-6. PubMed ID: 21084862
[TBL] [Abstract][Full Text] [Related]
5. Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway.
Li Y; Zhou H; Li F; Chan SW; Lin Z; Wei Z; Yang Z; Guo F; Lim CJ; Xing W; Shen Y; Hong W; Long J; Zhang M
Cell Res; 2015 Jul; 25(7):801-17. PubMed ID: 26045165
[TBL] [Abstract][Full Text] [Related]
6. Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus.
Li W; Cooper J; Karajannis MA; Giancotti FG
EMBO Rep; 2012 Mar; 13(3):204-15. PubMed ID: 22482125
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of DDB1-and-Cullin 4-associated Factor 1 (DCAF1) recognition by merlin/NF2 and its implication in tumorigenesis by CD44-mediated inhibition of merlin suppression of DCAF1 function.
Mori T; Gotoh S; Shirakawa M; Hakoshima T
Genes Cells; 2014 Aug; 19(8):603-19. PubMed ID: 24912773
[TBL] [Abstract][Full Text] [Related]
8. NEDD4L-mediated Merlin ubiquitination facilitates Hippo pathway activation.
Wei Y; Yee PP; Liu Z; Zhang L; Guo H; Zheng H; Anderson B; Gulley M; Li W
EMBO Rep; 2020 Dec; 21(12):e50642. PubMed ID: 33058421
[TBL] [Abstract][Full Text] [Related]
9. Merlin, a multi-suppressor from cell membrane to the nucleus.
Zhou L; Hanemann CO
FEBS Lett; 2012 May; 586(10):1403-8. PubMed ID: 22595235
[TBL] [Abstract][Full Text] [Related]
10. Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.
Li W; Cooper J; Zhou L; Yang C; Erdjument-Bromage H; Zagzag D; Snuderl M; Ladanyi M; Hanemann CO; Zhou P; Karajannis MA; Giancotti FG
Cancer Cell; 2014 Jul; 26(1):48-60. PubMed ID: 25026211
[TBL] [Abstract][Full Text] [Related]
11. Conformational flexibility determines the Nf2/merlin tumor suppressor functions.
Primi MC; Rangarajan ES; Patil DN; Izard T
Matrix Biol Plus; 2021 Dec; 12():100074. PubMed ID: 34337379
[TBL] [Abstract][Full Text] [Related]
12. Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses
Cooper J; Xu Q; Zhou L; Pavlovic M; Ojeda V; Moulick K; de Stanchina E; Poirier JT; Zauderer M; Rudin CM; Karajannis MA; Hanemann CO; Giancotti FG
Mol Cancer Ther; 2017 Aug; 16(8):1693-1704. PubMed ID: 28468780
[TBL] [Abstract][Full Text] [Related]
13. Multistep phosphorylation by oncogenic kinases enhances the degradation of the NF2 tumor suppressor merlin.
Laulajainen M; Muranen T; Nyman TA; Carpén O; Grönholm M
Neoplasia; 2011 Jul; 13(7):643-52. PubMed ID: 21750658
[TBL] [Abstract][Full Text] [Related]
14. Merlin, the NF2 gene product.
Pećina-Šlaus N
Pathol Oncol Res; 2013 Jul; 19(3):365-73. PubMed ID: 23666797
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of the binding of Merlin FERM domain to the E3 ubiquitin ligase substrate adaptor DCAF1.
Li Y; Wei Z; Zhang J; Yang Z; Zhang M
J Biol Chem; 2014 May; 289(21):14674-81. PubMed ID: 24706749
[TBL] [Abstract][Full Text] [Related]
16. NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma.
Sato T; Sekido Y
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587439
[TBL] [Abstract][Full Text] [Related]
17. Shedding light on Merlin's wizardry.
Okada T; You L; Giancotti FG
Trends Cell Biol; 2007 May; 17(5):222-9. PubMed ID: 17442573
[TBL] [Abstract][Full Text] [Related]
18. Merlin sumoylation is required for its tumor suppressor activity.
Qi Q; Liu X; Brat DJ; Ye K
Oncogene; 2014 Oct; 33(41):4893-903. PubMed ID: 24166499
[TBL] [Abstract][Full Text] [Related]
19. A tight junction-associated Merlin-angiomotin complex mediates Merlin's regulation of mitogenic signaling and tumor suppressive functions.
Yi C; Troutman S; Fera D; Stemmer-Rachamimov A; Avila JL; Christian N; Persson NL; Shimono A; Speicher DW; Marmorstein R; Holmgren L; Kissil JL
Cancer Cell; 2011 Apr; 19(4):527-40. PubMed ID: 21481793
[TBL] [Abstract][Full Text] [Related]
20. Merlin, a regulator of Hippo signaling, regulates Wnt/β-catenin signaling.
Kim S; Jho EH
BMB Rep; 2016 Jul; 49(7):357-8. PubMed ID: 27345717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]